Contineum Therapeutics
Clinical trials sponsored by Contineum Therapeutics, explained in plain language.
-
New pill shows promise for MS control in early trial
Disease control CompletedThis study tested an experimental oral drug called PIPE-307 in 182 adults with relapsing-remitting multiple sclerosis (MS). Participants took either a low or high dose of PIPE-307 or a placebo daily for about 30 weeks, alongside their usual MS medication. The goal was to see if t…
Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill aims to ease chronic pain without opioids
Symptom relief CompletedThis early-stage study tested whether an experimental pill called PIPE-791 is safe and can lower pain in adults with long-term osteoarthritis knee pain or chronic low back pain. 43 participants stopped their usual pain meds, then took either the study drug or a placebo daily for …
Phase: PHASE1 • Sponsor: Contineum Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC